FEATURED ARTICLES
-
3 Tips For Selecting Your eTMF Platform
Each eTMF platform presents its own set of advantages and drawbacks. Be sure to incorporate these three tips when considering a new eTMF vendor and its services.
-
Increasing The Usefulness Of PROs In Oncology Research
Dr. Anthony Everhart (Clinical VP, Internal Medicine, Signant Health) and Tim Meyer (Professor, Experimental Cancer Medicine, University College London) discuss opportunities for increasing the usefulness of PROMs.
-
Can We Break The Digital Barrier In Clinical Trials?
In a recent episode of Clinical Leader Live, a panel of experts explore the barriers and benefits of leveraging technology in clinical trials.
WHITE PAPERS AND CASE STUDIES
-
Unified Platform Solutions For Phase I Clinical Trials
Phase I clinical trials need technological solutions that support rapid implementation and end-to-end processes. Signant’s unified eClinical platform provides the perfect partner for Phase I research.
-
ePRO And Castor Connect
Gather data directly from the patient—the true source. Empower your team to streamline data collection, making it faster and easier for everyone involved.
-
eConsent Readiness In 24 Countries
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.
NEWS
- Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
- Exco InTouch Joins Critical Path Institute ePRO Consortium To Advance Electronic Data Capture In Clinical Trials
- ERT Expands Corporate Presence In Japan
- PHT Corporation Patents ‘Time Travel’ For Clinical Research
- No Differences In Quality Of Clinical Trial Data Across Regions, Reports Drug Information Journal